Inhibition of CEA release from epithelial cells by lipid A of Gram-negative bacteria

Area of Science:

• Microbiology and Immunology
• Cell Biology
• Gastroenterology

Background:

• Bacterial species utilize human CEACAM family members as entry receptors into epithelial cells.
• Glycosylphosphatidylinositol (GPI)-anchored CEA and CEACAM6 are implicated in colon innate immunity against microbial invasion.
• CEA is released from epithelial cells via a GPI-phospholipase D (GPI-PLD) enzyme, with activity inhibited by lipid A.

Purpose of the Study:

• To investigate if Gram-negative bacteria engagement with CEA attenuates CEA release from epithelial cells.
• To determine if reduced CEA release facilitates bacterial colonization.
• To examine the effect of Escherichia coli on CEA release from colorectal cancer cells.

Main Methods:

• Co-culture experiments using colorectal cancer cell lines (LS-180, Caco-2, HT29/219) and Escherichia coli.
• Measurement of CEA secretion and shedding from treated and untreated cells.
• Lipid A treatment of LS-180 cells to assess dose-dependent effects on CEA release.
• Western blot analysis to evaluate CEA expression levels in cellular lysates.

Main Results:

• Significant reduction in CEA secretion observed in LS-180 and HT29/219 cells upon incubation with E. coli.
• Minimal reduction in CEA shedding from Caco-2 cells compared to controls.
• Lipid A treatment inhibited CEA release from LS-180 cells in a dose-dependent manner.
• No significant difference in CEA expression levels within cells co-cultured with bacteria versus controls.

Conclusions:

• Lipid A from Gram-negative bacteria may inhibit the release of CEA from mucosal surfaces.
• This inhibition mechanism could promote bacterial colonization of the colon.
• The findings highlight a potential role for bacterial lipid A in modulating host-microbe interactions at the mucosal barrier.